Skip to main content

A Network-Based Approach to Identify Molecular Signatures and Comorbidities of Thyroid Cancer

  • Conference paper
  • First Online:
Proceedings of International Joint Conference on Computational Intelligence

Part of the book series: Algorithms for Intelligent Systems ((AIS))

Abstract

The molecular mechanisms driving thyroid cancer (TC) development and progression are poorly understood, but identifying molecular pathways and hub genes abnormally active in TC tissues may highlight some of the key pathogenic processes involved. We therefore analysed TC tissue transcriptome profiles to identify such pathways which were then functionally characterized. Thus, we studied microarray gene expression dataset to identify the differentially expressed genes (DEGs) in TC compared to normal thyroid tissues. By using topological and neighbourhood based benchmark methods, we built comorbidity relationship networks to clarify how TC molecular pathways related to those of other diseases considering our identified significant DEGs of TC and assessed their functions using Online Mendelian Inheritance in Man (OMIM) databases, protein-protein interaction (PPI) networks. TC tissues showed dysregulation in expression of 598 genes, of which 133 had increased and 465 had decreased expression. From the analysis of the comorbidity network (gene-disease associations network; GDN), we identified 24 genes previously shown to be strongly associated with cancer, 24 genes associated with neurological disorders and 14 genes associated with cardiovascular disease. PPI network were built around the identified 79 unique genes in GDN of TC to identify the shared proteins group of different diseases. From the analysis of PPI network, we identified 10 significant hub genes namely EGFR, KIT, IRS1, KDR, BUB1B, CDH1, BUB1, TEK, TPM2 and NR4A2 based on the degree and betweenness centrality. Moreover, transcription factors (TFs) that may influence the observed TC gene expression were identified. Thus, our study identified DEGs, molecular pathways, hub genes, TFs and miRNAs of TC, as well as comorbidities with other diseases. The TC-associated genes thus identified comprised candidates for further studies to identify new TC biomarkers and pathological processes that underlie TC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amberger J, Bocchini C, Hamosh A (2011) A new face and new challenges for online mendelian inheritance in man (omim®). Hum Mutat 32(5):564–567

    Article  Google Scholar 

  2. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R (2006) NCBI GEO: mining tens of millions of expression profiles database and tools update. Nucl Acids Res 35(suppl\(\_\)1):D760–D765

    Article  Google Scholar 

  3. Gilabert M, Prebet T (2012) Acute leukemia arising after radioiodine treatment for thyroid cancer. Haematologica, 97(8):e28–e29

    Article  Google Scholar 

  4. Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L (2007) The human disease network. Proc Natl Acad Sci 104(21):8685–8690

    Article  Google Scholar 

  5. Hossain MA, Asa TA, Quinn JM, Rahman MM, Huq F, Moni MA (2018) Network-based genetic profiling, and therapeutic target identification of thyroid cancer. BioRxiv, 480632

    Google Scholar 

  6. Hossain MA, Islam SM, Quinn J, Huq F, Moni MA (2018) Identification of ovarian cancer gene expression patterns associated with disease progression and mortality. BioRxiv, 473165

    Google Scholar 

  7. Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, Udelsman R, Zhang Y (2013) The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23(5):575–582

    Article  Google Scholar 

  8. LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195(2):127–137

    Article  Google Scholar 

  9. Lin Y-P, Iqbal U, Nguyen P-A, Islam MM, Atique S, Jian W-S, Li Y-CJ, Huang C-L, Hsu C-H (2017) The concomitant association of thyroid disorders and myasthenia gravis. Transl Neurosci 8(1):27–30

    Article  Google Scholar 

  10. Ma Y, Xiao T, Xu Q, Shao X, Wang H (2016) Itraq-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer. Front Med 10(3):278–285

    Article  Google Scholar 

  11. Mardilovich K, Pankratz SL, Shaw LM (2009) Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 7(1):14

    Article  Google Scholar 

  12. Moni MA, Liò P (2014) comor: a software for disease comorbidity risk assessment. J Clin Bioinform 4(1):1

    Article  Google Scholar 

  13. Moni MA, Liò P (2014) Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinform 15(1):1

    Article  Google Scholar 

  14. Moni MA, Lio’ P (2017) Genetic profiling and comorbidities of zika infection. J Infect Dis 216(6):703–712

    Article  Google Scholar 

  15. Moni MA, Xu H, Lio P (2014) Cytocom: a cytoscape app to visualize, query and analyse disease comorbidity networks. Bioinformatics 31(6):969–971

    Article  Google Scholar 

  16. Ouyang B, Knauf JA, Ain K, Nacev B, Fagin JA (2002) Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin Endocrinol 56(3):341–350

    Article  Google Scholar 

  17. Peyressatre M, Prével C, Pellerano M, Morris MC (2015) Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors. Cancers 7(1):179–237

    Article  Google Scholar 

  18. Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, et al (2018) Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin Cancer Res 0373

    Google Scholar 

  19. Wojtas B, Pfeifer A, Oczko-Wojciechowska M, Krajewska J, Czarniecka A, Kukulska A, Eszlinger M, Musholt T, Stokowy T, Swierniak M et al (2017) Gene expression (mRNA) markers for differentiating between malignant and benign follicular thyroid tumours. Int J Mol Sci 18(6):1184

    Article  Google Scholar 

  20. Ye K, Li J, Li X, Chang S, Zhang Z (2018) Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway. Oncol Lett 15(1):1313–1318

    Google Scholar 

  21. Zhang J, Zhang J, Xu S, Zhang X, Wang P, Wu H, Xia B, Zhang G, Lei B, Wan L et al (2018) Hypoxia-induced TPM2 methylation is associated with chemoresistance and poor prognosis in breast cancer. Cell Physiol Biochem 45(2):692–705

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Ali Moni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Ali Hossain, M., Asa, T.A., Huq, F., Quinn, J.M.W., Moni, M.A. (2020). A Network-Based Approach to Identify Molecular Signatures and Comorbidities of Thyroid Cancer. In: Uddin, M., Bansal, J. (eds) Proceedings of International Joint Conference on Computational Intelligence. Algorithms for Intelligent Systems. Springer, Singapore. https://doi.org/10.1007/978-981-13-7564-4_21

Download citation

Publish with us

Policies and ethics